BRIEF-Lannett seeks to withdraw approval of abbreviated NDA for methylphenidate hydrochloride extended release tablets
October 19, 2016 at 07:20 AM EDT
* Lannett comments on FDA proposal regarding methylphenidate extended release tablets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.